David A. Siegel Affimed N.V. Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.32 - $0.62 $16,352 - $31,682	-51,100 Reduced 6.9%	689,870 $427,000
Q3 2023 Nov 14, 2023	BUY	$0.46 - $0.65 $34,638 - $48,945	75,300 Added 11.31%	740,970 $355,000
Q2 2023 Aug 14, 2023	BUY	$0.57 - $1.08 $138,510 - $262,440	243,000 Added 57.49%	665,670 $399,000
Q1 2023 May 15, 2023	BUY	$0.66 - $1.29 $125,862 - $246,003	190,700 Added 82.21%	422,670 $317,000
Q4 2022 Feb 14, 2023	BUY	$1.1 - $2.45 $210,870 - $469,665	191,700 Added 476.04%	231,970 $287,000
Q3 2022 Nov 14, 2022	SELL	$1.96 - $3.32 $133,476 - $226,092	-68,100 Reduced 62.84%	40,270 $83,000
Q2 2022 Aug 15, 2022	SELL	$2.27 - $4.86 $149,593 - $320,274	-65,900 Reduced 37.81%	108,370 $300,000
Q1 2022 May 16, 2022	SELL	$3.69 - $5.65 $608,481 - $931,685	-164,900 Reduced 48.62%	174,270 $762,000
Q4 2021 Feb 14, 2022	SELL	$5.37 - $7.07 $3.93 Million - $5.17 Million	-731,300 Reduced 68.32%	339,170 $1.87 Million
Q3 2021 Nov 15, 2021	SELL	$5.54 - $7.51 $1.01 Million - $1.37 Million	-183,000 Reduced 14.6%	1,070,470 $6.62 Million
Q2 2021 Aug 16, 2021	BUY	$7.78 - $11.4 $2.23 Million - $3.27 Million	286,600 Added 29.64%	1,253,470 $10.7 Million
Q1 2021 May 17, 2021	BUY	$5.12 - $8.48 $1.13 Million - $1.87 Million	220,800 Added 29.6%	966,870 $7.65 Million
Q4 2020 Feb 16, 2021	BUY	$3.16 - $7.03 $951,160 - $2.12 Million	301,000 Added 67.63%	746,070 $4.34 Million
Q3 2020 Nov 16, 2020	BUY	$3.26 - $4.73 $920,623 - $1.34 Million	282,400 Added 173.6%	445,070 $1.51 Million
Q2 2020 Aug 14, 2020	BUY	$1.58 - $4.63 $241,108 - $706,538	152,600 Added 1515.39%	162,670 $751,000
Q1 2020 May 15, 2020	BUY	$1.44 - $3.02 $14,500 - $30,411	10,070 New	10,070 $16,000
Q3 2019 Nov 14, 2019	SELL	$2.67 - $3.65 $136,623 - $186,770	-51,170 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$2.6 - $4.21 $133,042 - $215,425	51,170 New	51,170 $147,000

Others Institutions Holding AFMD

# of Institutions

Shares Held

1.09M

Call Options Held

Put Options Held

View Full List

About Affimed N.V.

Ticker AFMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,339,008
Market Cap $185M
Description
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...

More about AFMD

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account